People with more of the fish-oil fat DHA in their blood became frail less often

Frailty is the state in which the body's reserves run low: people walk more slowly, tire easily, lose strength and weight, and are more likely to fall, end up in hospital or die. Long-lasting low-grade inflammation is thought to be one driver.

Omega-3 fats are a family of fats the body needs but cannot make well on its own. Two of them, EPA and DHA, come mainly from oily fish; a third, ALA, comes from plants such as flaxseed. They are known to damp down inflammation. Many studies have found that people who eat more fish are less often frail, and the same research group had earlier linked higher blood DHA to less frailty in UK and Korean older adults. Most of that earlier work was a snapshot, though: it compared people at one point in time. This study asks whether blood levels measured today predict who becomes frail years later.

What they did

The researchers, at Hanyang University in South Korea and the University of South Dakota, used the UK Biobank, a large study of British volunteers aged 40 to 69 at recruitment. They included 38,577 people who were not frail at the start, had their blood omega-3 levels measured, and came back for at least one later check. Their average age at the start was about 55.

Blood levels of DHA and of all omega-3 fats together were measured once, at the start, as a share of all fats in the blood. Frailty was defined by the widely used Fried criteria: meeting at least three of five signs (little physical activity, exhaustion, slow walking, weight loss and weak grip).

The analysis took into account age, sex, ethnicity, smoking, alcohol, body weight and waist size, education, income, employment, household size, social contact and sleep.

What they found

• 1,024 people became frail over a median of 9.4 years.
• Higher DHA, less frailty. Comparing people with high DHA (the 90th percentile) with people with low DHA (the 10th percentile), the rate of new frailty was 18% lower.
• A threshold rather than a straight line. The lowest fifth of DHA levels stood out: the risk was lower in all four higher fifths compared with that bottom group. The authors suggest that the benefit may level off once DHA is above about 1.5% of blood fats.
• Only DHA. The other omega-3 fats, alone or all together, were not clearly linked to frailty.
• Which signs of frailty? Higher DHA went with less new low physical activity and less exhaustion. It was not linked to weak grip, slow walking or weight loss.

What to keep in mind

• Association only. This is an observational study. People with more DHA in their blood may differ in other ways the adjustments did not capture, and the authors acknowledge that unmeasured factors may have played a role.
• Mostly middle-aged. The average participant was about 55 at the start, so the authors caution that the results may not apply directly to older people.
• Rough measures. Walking speed and weight loss were self-reported, and weight loss was not marked as unintentional. DHA was measured only once.
• Who was included. Only people who came back for a follow-up visit and had blood fat data could be studied, a small part of the half-million UK Biobank volunteers.
• A possible interest. One author owns shares in a company that offers blood fatty acid tests.
• Supplements are a different question. The authors call for trials to test whether taking DHA lowers frailty risk. A recent two-year trial of high-dose DHA for the brain in older adults found no benefit for memory (/post/2026-10-23-high-dose-dha-brain-no-benefit/), a reminder that blood-level links do not always translate into effects of pills.

Why it matters

Frailty is one of the main reasons older people lose independence, and a simple blood marker that flags who is at higher risk could help target prevention. This study, with tens of thousands of people and nearly a decade of follow-up, adds to the evidence that low DHA in the blood goes together with a higher chance of becoming frail. Whether raising DHA, through diet or supplements, would change that risk has not been shown.